Arch Pharmalabs
BSE: 524729 | NSE: N.A | ISIN: INE182F01017 | Pharmaceuticals
 |
 |
Yearly Results of Arch Pharmalabs |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Mar '95 | Mar '97 | Mar '98 | Mar '04 | Mar '05 | ||||||
|
||||||||||
| Sales Turnover | 5.01 | 8.84 | 2.62 | 96.46 | 155.68 | |||||
| Other Income | 0.74 | 0.29 | 3.00 | 0.31 | 0.26 | |||||
| Total Income | 5.75 | 9.13 | 5.63 | 96.77 | 155.93 | |||||
| Total Expenses | 4.90 | 7.64 | 4.78 | 79.36 | 127.16 | |||||
| Operating Profit | 0.11 | 1.20 | -2.16 | 17.10 | 28.52 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 0.85 | 1.49 | 0.84 | 17.41 | 28.78 | |||||
| Interest | 0.16 | 2.25 | 2.45 | 6.19 | 9.27 | |||||
| PBDT | 0.69 | -0.76 | -1.61 | 11.23 | 19.52 | |||||
| Depreciation | 0.04 | 0.67 | 0.66 | 1.10 | 3.32 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 0.65 | -1.43 | -2.27 | 10.13 | 16.20 | |||||
| Tax | -- | -- | -- | 1.20 | 5.00 | |||||
| Net Profit | 0.65 | -1.43 | -2.27 | 8.93 | 11.20 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 0.80 | -- | -- | 10.23 | 8.50 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 8.10 | 8.10 | 8.10 | 8.73 | 13.17 | |||||
| Reserves | 0.65 | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Arch Pharmalabs connections | ||||||||||
| ||||||||||
